All premium reports for Therapy Industry Analysis and Statistics (since 2008 - p4)

 

91-120 of 150 Premium Reports from 16 Publishers

Cancer Gastrointestinal (Stomach) Cancer

Cancer Gastrointestinal (Stomach) Cancer

  • $ 1 495
  • March 2009

Life Science Analytics', Cancer Gastrointestinal (Stomach) Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of gastrointestinal (stomach) cancer drugs by company and by stage as well as a summary of the latest news and developme ...

Industries : Therapy

Cancer Head and Neck Cancer

Cancer Head and Neck Cancer

  • $ 1 495
  • March 2009

Life Science Analytics', Cancer Head and Neck Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of head and neck cancer drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of ...

Industries : Therapy

Cancer Kidney Cancer

Cancer Kidney Cancer

  • $ 1 495
  • March 2009

Life Science Analytics', Cancer Kidney Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of kidney cancer drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report:Eac ...

Industries : Therapy

Cancer Liver Cancer

Cancer Liver Cancer

  • $ 1 495
  • March 2009

Life Science Analytics', Cancer Liver Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of liver cancer drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report:Each ...

Industries : Therapy

Cancer Lymphoma

Cancer Lymphoma

  • $ 1 495
  • March 2009

Life Science Analytics', Cancer Lymphoma contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of lymphoma drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report:Each Life Sci ...

Industries : Therapy

Cancer Melanoma or Skin Cancer

Cancer Melanoma or Skin Cancer

  • $ 1 495
  • March 2009

Life Science Analytics', Cancer Melanoma or Skin Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of melanoma or skin cancer drugs by company and by stage as well as a summary of the latest news and developments in this area.Sco ...

Industries : Therapy

Cancer Multiple Myeloma

Cancer Multiple Myeloma

  • $ 1 495
  • March 2009

Life Science Analytics', Cancer Multiple Myeloma contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of multiple myeloma drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the repo ...

Industries : Therapy

Cancer Non-Hodgkin Lymphoma

Cancer Non-Hodgkin Lymphoma

  • $ 1 495
  • March 2009

Life Science Analytics', Cancer Non-Hodgkin Lymphoma contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of non-hodgkin lymphoma drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of ...

Industries : Therapy

Cancer Non-Small-Cell Lung Cancer or Lung Cancer or Small Cell Lung Cancer

Cancer Non-Small-Cell Lung Cancer or Lung Cancer or Small Cell Lung Cancer

  • $ 1 495
  • March 2009

Life Science Analytics', Cancer Non-Small-Cell Lung Cancer or Lung Cancer or Small Cell Lung Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of non-small-cell lung cancer or lung cancer or small cell lung cancer drugs by compan ...

Industries : Therapy

Cancer Ovarian Cancer

Cancer Ovarian Cancer

  • $ 1 495
  • March 2009

Life Science Analytics', Cancer Ovarian Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of ovarian cancer drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report:E ...

Industries : Therapy

Cancer Pancreatic Cancer

Cancer Pancreatic Cancer

  • $ 1 495
  • March 2009

Life Science Analytics', Cancer Pancreatic Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of pancreatic cancer drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the re ...

Industries : Therapy

Cancer Prostate Cancer

Cancer Prostate Cancer

  • $ 1 495
  • March 2009

Life Science Analytics', Cancer Prostate Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of prostate cancer drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report ...

Industries : Therapy

Central Nervous System Alzheimer Disease

Central Nervous System Alzheimer Disease

  • $ 1 495
  • March 2009

Life Science Analytics', Central Nervous System Alzheimer Disease contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of alzheimer disease drugs by company and by stage as well as a summary of the latest news and developments in this area ...

Industries : Therapy

Central Nervous System Amyotrophic Lateral Sclerosis

Central Nervous System Amyotrophic Lateral Sclerosis

  • $ 1 495
  • March 2009

Life Science Analytics', Central Nervous System Amyotrophic Lateral Sclerosis contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of amyotrophic lateral sclerosis drugs by company and by stage as well as a summary of the latest news and d ...

Industries : Therapy

Central Nervous System Anxiety

Central Nervous System Anxiety

  • $ 1 495
  • March 2009

Life Science Analytics', Central Nervous System Anxiety contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of anxiety drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report ...

Industries : Therapy

Central Nervous System Attention Deficit Disorder with Hyperactivity

Central Nervous System Attention Deficit Disorder with Hyperactivity

  • $ 1 495
  • March 2009

Life Science Analytics', Central Nervous System Attention Deficit Disorder with Hyperactivity contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of attention deficit disorder with hyperactivity drugs by company and by stage as well as a ...

Industries : Therapy

Central Nervous System Bipolar Disorder

Central Nervous System Bipolar Disorder

  • $ 1 495
  • March 2009

Life Science Analytics', Central Nervous System Bipolar Disorder contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of bipolar disorder drugs by company and by stage as well as a summary of the latest news and developments in this area.S ...

Industries : Therapy

Central Nervous System Dementia

Central Nervous System Dementia

  • $ 1 495
  • March 2009

Life Science Analytics', Central Nervous System Dementia contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of dementia drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the repo ...

Industries : Therapy

Central Nervous System Depression

Central Nervous System Depression

  • $ 1 495
  • March 2009

Life Science Analytics', Central Nervous System Depression contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of depression drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the ...

Industries : Therapy

Central Nervous System Epilepsy

Central Nervous System Epilepsy

  • $ 1 495
  • March 2009

Life Science Analytics', Central Nervous System Epilepsy contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of epilepsy drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the repo ...

Industries : Therapy

Central Nervous System Headache

Central Nervous System Headache

  • $ 1 495
  • March 2009

Life Science Analytics', Central Nervous System Headache contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of headache drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the repo ...

Industries : Therapy

Central Nervous System Huntington Disease

Central Nervous System Huntington Disease

  • $ 1 495
  • March 2009

Life Science Analytics', Central Nervous System Huntington Disease contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of huntington disease drugs by company and by stage as well as a summary of the latest news and developments in this a ...

Industries : Therapy

Central Nervous System Insomnia or Sleep Disorders

Central Nervous System Insomnia or Sleep Disorders

  • $ 1 495
  • March 2009

Life Science Analytics', Central Nervous System Insomnia or Sleep Disorders contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of insomnia or sleep disorders drugs by company and by stage as well as a summary of the latest news and devel ...

Industries : Therapy

Central Nervous System Memory Impairment

Central Nervous System Memory Impairment

  • $ 1 495
  • March 2009

Life Science Analytics', Central Nervous System Memory Impairment contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of memory impairment drugs by company and by stage as well as a summary of the latest news and developments in this area ...

Industries : Therapy

Central Nervous System Migraine

Central Nervous System Migraine

  • $ 1 495
  • March 2009

Life Science Analytics', Central Nervous System Migraine contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of migraine drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the repo ...

Industries : Therapy

Central Nervous System Multiple Sclerosis

Central Nervous System Multiple Sclerosis

  • $ 1 495
  • March 2009

Life Science Analytics', Central Nervous System Multiple Sclerosis contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of multiple sclerosis drugs by company and by stage as well as a summary of the latest news and developments in this a ...

Industries : Therapy

Central Nervous System Myasthenia Gravis

Central Nervous System Myasthenia Gravis

  • $ 1 495
  • March 2009

Life Science Analytics', Central Nervous System Myasthenia Gravis contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of myasthenia gravis drugs by company and by stage as well as a summary of the latest news and developments in this area ...

Industries : Therapy

Central Nervous System Neuralgia

Central Nervous System Neuralgia

  • $ 1 495
  • March 2009

Life Science Analytics', Central Nervous System Neuralgia contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of neuralgia drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the re ...

Industries : Therapy

Central Nervous System Neuropathy

Central Nervous System Neuropathy

  • $ 1 495
  • March 2009

Life Science Analytics', Central Nervous System Neuropathy contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of neuropathy drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the ...

Industries : Therapy

Central Nervous System Obsessive-Compulsive Disorder

Central Nervous System Obsessive-Compulsive Disorder

  • $ 1 495
  • March 2009

Life Science Analytics', Central Nervous System Obsessive-Compulsive Disorder contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of obsessive-compulsive disorder drugs by company and by stage as well as a summary of the latest news and d ...

Industries : Therapy

reportlinker.com © Copyright 2009. All rights reserved

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.